Lipid and lipoprotein metabolism in chronic kidney disease.
Abstract
The risk of cardiovascular events and mortality increases as renal function declines although the relative risk of mortality contributed by the standard Framingham risk factors are altered or replaced. Low-density lipoprotein (LDL) cholesterol does not predict mortality but low high-density lipoprotein (HDL) cholesterol and triglycerides remain risk factors. The lipoproteins within each class are shifted to smaller, more dense isoforms. The accumulation of apolipoprotein B-containing lipoproteins, including lipoprotein(a) results primarily from decreased clearance rather than from increased synthesis. Lipoprotein(a) levels are also associated with cardiovascular outcome among dialysis patients. Decreased clearance of very low-density lipoprotein and intermediate-density lipoprotein is a result of decreased lipoprotein lipase, structural alterations in the lipoproteins rendering them poorer substrates, and a decrease in receptor number for these proteins. HDL levels are decreased as a result of an increased fractional catabolic rate both among obese patients with normal renal function and among dialysis patients, but the mechanisms responsible for increased HDL fractional catabolic rate may differ. In patients with advanced kidney disease, HDL fails to mature normally as a result of decreased lecithin cholesterol ester transfer protein, leaving cholesterol ester-poor, triglyceride-rich HDL(3) and pre-beta HDL. HDL in patients with chronic kidney disease is a less effective antioxidative agent than is HDL from normal subjects because of a decrease in paroxonase activity, allowing the accumulation of oxidized LDL.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hypertriglyceridemia is common in patients with renal failure and may be related to decreased clearance of triglyceride-rich lipoproteins via reduced LpL and hepatic lipase activities.
“Hypertriglyceridemia is common in patients with renal failure and may be related to decreased clearance of triglyceride-rich lipoproteins via reduced LpL and hepatic lipase activities (104).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [104]
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369 · see citing works
Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults
Kurella, M., Lo, J. C., & Chertow, G. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010106 · Cited by 709 · see citing works
Muntner, P., Coresh, J., Smith, J. C., Eckfeldt, J., & Klag, M. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00165.x · Cited by 667 · see citing works
Garvey, W. T., Kwon, S., Zheng, D., Shaughnessy, S., Wallace, P., Hutto, A. C., Pugh, K. B., Jenkins, A. J., Klein, R. L., & Liao, Y. (2003) · Diabetes · doi:10.2337/diabetes.52.2.453 · Cited by 606 · see citing works
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
Vaziri, N. D. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00099.2005 · Cited by 542 · see citing works
Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease
Muntner, P., He, J., Astor, B. C., Folsom, A. R., & Coresh, J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080656 · Cited by 490 · see citing works
Lackner, C., Boerwinkle, E., Leffert, C. C., Rahmig, T., & Hobbs, H. H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115248 · Cited by 406 · see citing works
Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients
Iseki, K., Yamazato, M., Tozawa, M., & Takishita, S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00324.x · Cited by 381 · see citing works
Remodelling of high density lipoproteins by plasma factors
Rye, K., Clay, M. A., & Barter, P. J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00150-1 · Cited by 272 · see citing works
Insulin resistance in patients with chronic kidney disease
Kobayashi, S., Maesato, K., Moriya, H., Ohtake, T., & Ikeda, T. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.09.034 · Cited by 252 · see citing works
Kronenberg, F., Kuen, E., Ritz, E., Junker, R., Diaeresis]NIG, P. K., KRAATZ, G. D., Lhotta, K., Mann, J. F. E., DiaeresisLLER, G. A. M., Neyer, U., et al. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v111105 · Cited by 246 · see citing works
Elshourbagy, N. A., Boguski, M. S., Liao, W. S. ‐., Jefferson, L. S., Gordon, J. I., & Taylor, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.8242 · Cited by 226 · see citing works
Effect of Variability in Anemia Management on Hemoglobin Outcomes in ESRD
Lacson, E., Ofsthun, N. J., & Lazarus, J. M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50030 · Cited by 196 · see citing works
Shoji, T., Nishizawa, Y., Kawagishi, T., Kawasaki, K., Taniwaki, H., Tabata, T., Inoue, T., & Morii, H. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v971277 · Cited by 183 · see citing works
Stompór, T. P., Pasowicz, M., Sułowicz, W., Dembinska-Kiec, A., Janda, K., Wójcik‐Pszczoła, K., Tracz, W., Zdzienicka, A., Klimeczek, P., & Janusz-Grzybowska, E. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50005 · Cited by 164 · see citing works
Deighan, C. J., CASLAKE, M. J., McConnell, M., Boulton‐Jones, J. M., & Packard, C. J. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70255-1 · Cited by 140 · see citing works
Berbée, J. F. P., van der Hoogt, C. C., Sundararaman, D., Havekes, L. M., & Rensen, P. C. N. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400301-jlr200 · Cited by 137 · see citing works
Sparks, D. L., Davidson, W. S., Lund‐Katz, S., & Phillips, M. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26910 · Cited by 110 · see citing works
Koch, M., Kutkuhn, B., Grabensee, B., & Ritz, E. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.12.2603 · Cited by 105 · see citing works
In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients
Frischmann, M. E., Kronenberg, F., Trenkwalder, E., Schaefer, J. R., Schweer, H., Dieplinger, B., Koenig, P., Ikewaki, K., & Dieplinger, H. (2007) · Kidney International · doi:10.1038/sj.ki.5002131 · Cited by 101 · see citing works
Thomas, H. E., & Kay, T. W. H. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200007/08)16:4 · Cited by 100 · see citing works
Longenecker, J. C., Klag, M. J., Marcovina, S. M., Liu, Y., Jaar, B. G., Powe, N. R., Fink, N. E., Levey, A. S., & Coresh, J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110922 · Cited by 93 · see citing works
Pietzsch, J., Julius, U., Nitzsche, S., & Markolf Hanefeld, E. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1928 · Cited by 86 · see citing works
Evidence for increased synthesis of lipoprotein(a) in the nephrotic syndrome.
der Velden, M. G. M. D. S., Reijngoud, D., Kaysen, G. A., Gadellaa, M. M., Voorbij, H. A. M., Stellaard, F., Koomans, H. A., & Rabelink, T. J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v981474 · Cited by 83 · see citing works
Self-citationMiida, T., Miyazaki, O., Hanyu, O., Nakamura, Y., Hirayama, S., Narita, I., Gejyo, F., Ei, I., Tasaki, K., Kohda, Y., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000046962.43220.8a · Cited by 76 · see citing works
Ikewaki, K., Schaefer, J. R., Frischmann, M. E., Okubo, K., Hosoya, T., Mochizuki, S., Dieplinger, B., Trenkwalder, E., Schweer, H., Kronenberg, F., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000188555.60475.c2 · Cited by 74 · see citing works
Morena-Carrere, M., Cristol, J., DANTOINE, T. F., Carbonneau, M., Descomps, B., & Canaud, B. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.3.389 · Cited by 72 · see citing works
Bayés, B., Pastor, M. C., Bonal, J., Foraster, A., & Romero, R. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi294 · Cited by 72 · see citing works
Hirano, T., Sakaue, T., Misaki, A., Murayama, S., Takahashi, T., Okada, K., Takeuchi, H. T., Yoshino, G., & Adachi, M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00019.x · Cited by 56 · see citing works
Rozek, L. S., Hatsukami, T. S., Richter, R. J., Ranchalis, J., Nakayama, K. S., McKinstry, L. A., Gortner, D. A., Boyko, E. J., Schellenberg, G. D., Furlong, C. E., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400489-jlr200 · Cited by 56 · see citing works
High‐density Lipoprotein Apolipoprotein A‐I Kinetics in Obesity
Ooi, E. M. M., Watts, G. F., Farvid, M. S., Chan, D. C., Allen, M. C., Zilko, S. R., & Barrett, P. H. R. (2005) · Obesity Research · doi:10.1038/oby.2005.118 · Cited by 45 · see citing works
Welty, F. K., Lichtenstein, A. H., Barrett, P. H. R., Dolnikowski, G. G., & Schaefer, E. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000137975.14996.df · Cited by 43 · see citing works
GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD.
Lo, J. C., Go, A., Chandra, M., Fan, D., & Kaysen, G. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.07.011 · Cited by 37 · see citing works
Self-citationDautin, G., Soltani, Z., Ducloux, D., Gautier, T., de Barros, J.-P. P., Gambert, P., Lagrost, L., & Masson, D. (2007) · Kidney International · doi:10.1038/sj.ki.5002449 · Cited by 37 · see citing works
LDL and HDL subclass distribution in patients with end-stage renal diseases
Alabakovska, S. B., Todorova, B., Labudović, D. D., & Trajkovska, K. T. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00300-4 · Cited by 35 · see citing works
van der Hoogt, C. C., Berbée, J. F. P., Santo, S. M. S. E., Gerritsen, G., Krom, Y. D., van der Zee, A., Havekes, L. M., van Dijk, K. W., & Rensen, P. C. N. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.01.002 · Cited by 28 · see citing works
Wakabayashi, Y., Okubo, M., Shimada, H., Sato, N., 小出, 朝., Marumo, F., & Nakamura, H. (1987) · Metabolism · doi:10.1016/0026-0495(87)90087-4 · Cited by 27 · see citing works
Adipotoxicity and the insulin resistance syndrome.
Anderwald, C. H., & Roden, M. (2004) · PubMed · Cited by 23 · see citing works
Mendez, A. J., Pérez, G. O., & Hsia, S. L. (1988) · PubMed · Cited by 22 · see citing works
Mekki, K., Bouchenak, M., Remaoun, M., & Belleville, J. (2004) · PubMed · Cited by 20 · see citing works
Serum Lipoprotein(a) Concentration and Apo(a) Isoform under The Condition of Renal Dysfunction
Kuboyama, M., Ageta, M., Ishihara, T., Fujiura, Y., Kashio, N., & Ikushima, I. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.283 · Cited by 13 · see citing works
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887 · see citing works
Lipid management in patients with chronic kidney disease
Ferro, C. J., Mark, P. B., Kanbay, M., Sarafidis, P. A., Heine, G. H., Rossignol, P., Massy, Z. A., Mallamaci, F., Valdivielso, J. M., Małyszko, J., et al. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0072-9 · Cited by 275 · see citing works
Uremia Alters HDL Composition and Function
Holzer, M., Birner‐Gruenberger, R., Stojaković, T., El‐Gamal, D., Binder, V., Wadsack, C., Heinemann, Á., & Marsche, G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111144 · Cited by 269 · see citing works
Dyslipidemia in patients with chronic kidney disease
Hager, M., Narla, A. D., & Tannock, L. R. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9402-z · Cited by 188 · see citing works
Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.
Rahman, M., Yang, W., Akkina, S., Alper, A., Anderson, A. H., Appel, L., He, J., Raj, D., Schelling, J., Strauss, L., et al. (2014) · American Society of Nephrology. Clinical Journal · doi:10.2215/cjn.09320913 · Cited by 168 · see citing works
Dyslipidemia Associated with Chronic Kidney Disease
Tsimihodimos, V., Mitrogianni, Z., & Elisaf, M. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010041 · Cited by 174 · see citing works
Wang, Y., Zhang, Z., Liu, H.-J., Guo, Z.-Y., Zou, L., Zhang, Y., & Zhao, Y. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00947-x · Cited by 114 · see citing works
Keane, W. F., Tomassini, J. E., & Neff, D. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12849 · Cited by 97 · see citing works
Afshinnia, F., Rajendiran, T. M., Karnovsky, A., Soni, T., Wang, X., Xie, D., Yang, W. P., Shafi, T., Weir, M. R., He, J., et al. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.08.007 · Cited by 94 · see citing works
Reis, A., Rudnitskaya, A. M., Chariyavilaskul, P., Dhaun, N., Melville, V., Goddard, J. G., Webb, D. J., Pitt, A. R., & Spickett, C. M. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m055624 · Cited by 81 · see citing works
LDL cholesterol in CKD—to treat or not to treat?
Massy, Z. A., & de Zeeuw, D. (2013) · Kidney International · doi:10.1038/ki.2013.181 · Cited by 73 · see citing works
Cardiovascular Disease and Diabetic Kidney Disease
Maqbool, M., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.02.003 · Cited by 72 · see citing works
Samouilidou, E. C., Karpouza, A., Kostopoulos, V., Bakirtzi, T., Pantelias, K., Petras, D. I., Tzanatou-Exarchou, H., & Grapsa, E. J. (2011) · Renal Failure · doi:10.3109/0886022x.2011.641515 · Cited by 63 · see citing works
Mäkinen, V., Soininen, P., Kangas, A. J., Forsblom, C. M., Tolonen, N., Thorn, L. M., Viikari, J. S. A., Raitakari, O. T., Savolainen, M. J., Groop, P., et al. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12026 · Cited by 58 · see citing works
Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein
Kon, V., Yang, H., & Fazio, S. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.05.009 · Cited by 53 · see citing works
New Insights Into Lipid Metabolism in Chronic Kidney Disease
Kaysen, G. A. (2011) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2010.10.017 · Cited by 47 · see citing works
Self-citationManaging Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients
Lovre, D., Shah, S., Sihota, A., & Fonseca, V. A. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.006 · Cited by 48 · see citing works
Lipoprotein metabolism and CKD: overview
Barter, P. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0866-9 · Cited by 42 · see citing works
High-Density Lipoproteins and the Kidney
Strazzella, A., Ossoli, A., & Calabresi, L. (2021) · Cells · doi:10.3390/cells10040764 · Cited by 43 · see citing works
Treatment options for hypertriglyceridemia: From risk reduction to pancreatitis
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., & Stalenhoef, A. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.002 · Cited by 50 · see citing works
Chuang, A., Nguyen, M. T., Kung, W., Lehman, S. J., & Chew, D. P. (2020) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2020.02.17 · Cited by 40 · see citing works
Honda, H., Hirano, T., Ueda, M., Kojima, S., Mashiba, S., Hayase, Y., Michihata, T., & Shibata, T. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.30015 · Cited by 41 · see citing works
Marsche, G., Heine, G. H., Stadler, J. T., & Holzer, M. (2020) · Biomolecules · doi:10.3390/biom10091348 · Cited by 40 · see citing works
New Insights into Adiponectin and Leptin Roles in Chronic Kidney Disease
Coimbra, S., Rocha, S., Valente, M. J., Catarino, C., Bronze-da-Rocha, E., Belo, L., & Santos‐Silva, A. (2022) · Biomedicines · doi:10.3390/biomedicines10102642 · Cited by 35 · see citing works
Disorders of Lipid Metabolism and Chronic Kidney Disease in the Elderly
Choudhury, D., Tuncel, M., & Levi, M. (2009) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2009.07.006 · Cited by 29 · see citing works
Lipid Abnormalities in Patients with Chronic Kidney Disease
Keane, W. F., Tomassini, J. E., & Neff, D. (2011) · Contributions to nephrology · doi:10.1159/000327317 · Cited by 32 · see citing works
Dyslipidemia in renal disease: Causes, consequences and treatment
Mesquita, J., Varela, A. T. I. F., & Medina, J. L. (2010) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.06.003 · Cited by 32 · see citing works
Clinical assessment and management of dyslipidemia in patients with chronic kidney disease
Nitta, K. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0655-x · Cited by 32 · see citing works
Dyslipidemia in Patients with Kidney Disease
Thobani, A., & Jacobson, T. A. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.04.008 · Cited by 29 · see citing works
Concepts and Controversies: Lipid Management in Patients with Chronic Kidney Disease
Mathew, R. O., Rosenson, R. S., Lyubarova, R., Chaudhry, R., Costa, S. P., Bangalore, S., & Sidhu, M. S. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07020-x · Cited by 28 · see citing works
Chen, P., Huang, Y., Kao, Y., & Chen, J.-Y. (2010) · Journal of Nursing Research · doi:10.1097/jnr.0b013e3181dda726 · Cited by 27 · see citing works
Zoppini, G., Targher, G., Negri, C., Stoico, V., Gemma, M. L., & Bonora, E. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.04.035 · Cited by 24 · see citing works
The Roles of Fatty Acids and Apolipoproteins in the Kidneys
Pan, X. (2022) · Metabolites · doi:10.3390/metabo12050462 · Cited by 27 · see citing works
Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease
Samouilidou, E. C., Kostopoulos, V., Liaouri, A., Kiousi, E., Vassiliou, K., Bountou, E., & Grapsa, E. J. (2016) · Renal Failure · doi:10.3109/0886022x.2016.1144031 · Cited by 22 · see citing works
Coimbra, S., Reis, F., Nunes, S., Viana, S., Valente, M. J., Rocha, S., Catarino, C., Rocha‐Pereira, P., Bronze-da-Rocha, E., Sameiro-Faria, M., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3021785 · Cited by 22 · see citing works
Yen, C., Fan, P., Lin, M., Lee, C., Tu, K., Chen, C., Hsiao, C.-C., Hsu, H., Tian, Y., & Chang, C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab137 · Cited by 19 · see citing works
Gluba-Brzózka, A., Franczyk, B., Banach, M., & Rysz-Górzyńska, M. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1466-x · Cited by 19 · see citing works
Lipid-modifying therapy in chronic kidney disease: Pathophysiological and clinical considerations
Heine, G. H., Eller, K., Stadler, J. T., Rogacev, K. S., & Marsche, G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107459 · Cited by 19 · see citing works
Bakhshayeshkaram, M., Roozbeh, J., Heydari, S. T., Honarvar, B., Dabbaghmanesh, M. H., Ghoreyshi, M., & Lankarani, K. B. (2019) · Galen Medical Journal · doi:10.31661/gmj.v0i0.935 · Cited by 18 · see citing works
Filler, G., Taheri, S., McIntyre, C. W., Smith, C., Subramanian, L., Fusch, G., & Fusch, C. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx115 · Cited by 17 · see citing works
Wei, S., Liu, N.-M., Fu, Y.-L., & Sun, M. (2023) · Journal of Vascular Access · doi:10.1177/11297298221115557 · Cited by 15 · see citing works
Major influence of renal function on hyperlipidemia after living donor liver transplantation
Ling, Q. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i47.7033 · Cited by 16 · see citing works
Kachhawa, K., Varma, M., Kachhawa, P., Agrawal, D., Shaikh, M., & Kumar, S. (2016) · Journal of Health Research and Reviews · doi:10.4103/2394-2010.177494 · Cited by 16 · see citing works
Cardiovascular Risk Factors, Inflammation, and Corneal Arcus: The Singapore Malay Eye Study
Wu, R., Wang, J. J., Tai, E. S., & Wong, T. Y. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.04.028 · Cited by 16 · see citing works
Echida, Y., Ogawa, T., Otsuka, K., Ando, Y., & Nitta, K. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0615-5 · Cited by 16 · see citing works
López‐Olmos, V., Carreón‐Torres, E., Luna‐Luna, M., Flores‐Castillo, C., Martínez‐Ramírez, M., Bautista‐Pérez, R., Franco, M., Sandoval, J., Roldán, F., Aranda‐Fraustro, A., et al. (2016) · Lipids · doi:10.1007/s11745-016-4120-6 · Cited by 15 · see citing works
Triglyceride Treatment in the Age of Cholesterol Reduction
Agrawal, N., Corradi, P. F., Gumaste, N., & Goldberg, I. J. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.08.003 · Cited by 15 · see citing works
Yi, Y. J., Kim, H. J., Jo, S., Kim, S. G., Song, Y. R., Chung, W., Han, K. H., Lee, C. H., Hwang, Y., & Oh, K. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.06.005 · Cited by 14 · see citing works
Moradi, H., Said, H. M., & Vaziri, N. D. (2012) · Translational research · doi:10.1016/j.trsl.2012.11.001 · Cited by 14 · see citing works
Zhao, W.-B., Zhu, L., & Rahman, T. (2020) · Renal Failure · doi:10.1080/0886022x.2020.1745235 · Cited by 13 · see citing works
Lipid lowering in liver and chronic kidney disease
Herrick, C., Litvin, M., & Goldberg, A. C. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.11.006 · Cited by 12 · see citing works
Zhao, W.-B., & Alberto, D. L. P. S. M. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02550-7 · Cited by 10 · see citing works
Suh, S.-H.-O., Oh, T. R., Choi, H.-S., Kim, C., Bae, E., Ma, S., Oh, K., Han, S., & Kim, S. (2022) · Nutrients · doi:10.3390/nu14183792 · Cited by 11 · see citing works
Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dalcetrapib
Phelan, M., Anzures‐Cabrera, J., Carlile, D. J., Rowell, L., Kuhlmann, O., Arold, G., Robson, R. A., & Bentley, D. J. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0035-z · Cited by 10 · see citing works
Zhao, W., Li, J., Zhang, X., Zhou, X., Xu, J., Liu, X., & Liu, Z. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01241-7 · Cited by 9 · see citing works
Samouilidou, E. C., Karpouza, A., Grapsa, E. J., & Tzanatou-Exarchou, H. (2010) · Nephron Clinical Practice · doi:10.1159/000313488 · Cited by 9 · see citing works
To Eat or Not to Eat: Dietary Fat in Uremia Is the Question
Axelsson, T. G., Irving, G. F., & Axelsson, J. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00747.x · Cited by 8 · see citing works
Xiao, D., Wu, Q., Fan, W., Ye, X., Niu, J., & Gu, Y. (2013) · Hemodialysis International · doi:10.1111/hdi.12033 · Cited by 8 · see citing works
Bakillah, A., Tedla, F. M., Ayoub, I. M., John, D. G., Norin, A. J., Hussain, M. M., & Brown, C. D. (2015) · Mediators of Inflammation · doi:10.1155/2015/352356 · Cited by 8 · see citing works
Kim, C. H., Kim, S. J., Lee, M. J., Kwon, Y. E., Kim, Y. L., Park, K. S., Ryu, H. J., Oh, H. J., Han, S. H., Yoo, T., et al. (2014) · Blood Purification · doi:10.1159/000367803 · Cited by 6 · see citing works
Effects of Statins on Cardiovascular Outcomes in Patients With Chronic Kidney Disease
Kosmas, C. E., DeJesus, E., Sourla, E., Morcelo, R., Montan, P. D., & Guzman, E. (2017) · Clinical Medicine Insights Therapeutics · doi:10.1177/1179559x17719029 · Cited by 6 · see citing works
Yen, C., Fan, P., Lee, C., Chen, J., Chen, C., Tu, Y., Chu, P., Hsiao, C.-C., Chen, Y., & Chang, C. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1333553 · Cited by 5 · see citing works
Correlations of serum magnesium with dyslipidemia in patients on maintenance hemodialysis
Tony, E. E., Tohamy, M., Amin, N. F., Abdel-Aal, A. M., & Rahim, S. (2017) · Journal of The Egyptian Society of Nephrology and Transplantation · doi:10.4103/1110-9165.207900 · Cited by 5 · see citing works
Campbell, A. W., Sinatra, D. S., Zhang, Z., & Sinatra, S. T. (2020) · PubMed Central · Cited by 4 · see citing works
Lipid Abnormalities in Hemodialysis Patients
Ulusoy, Ş., & Ozk, G. (2013) · InTech eBooks · doi:10.5772/52925 · Cited by 4 · see citing works
Mistrík, E., Blaha, V., Sulková, S., Andrýs, C., Kalousová, M., & Sobotka, L. (2010) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2010.07.003 · Cited by 4 · see citing works
Effects of Statins on Cardiovascular Outcomes in Patients With Chronic Kidney Disease
Kosmas, C. E., DeJesus, E., Sourla, E., Morcelo, R., Montan, P. D., & Guzman, E. (2017) · doi:10.4137/cmt.s18871 · Cited by 4 · see citing works
Ábel, T., Benczúr, B., & Csajbókné, É. C. (2026) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-025-03965-w · Cited by 3 · see citing works
Ma, L.-Y., Fan, P., Chen, C., Tu, Y., Hsiao, C.-C., Yen, C., & Chang, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010168 · Cited by 3 · see citing works
Improving long‐term outcomes after pediatric renal transplantation by addressing dyslipidemia
Filler, G., & Medeiros-Domingo, M. (2017) · Pediatric Transplantation · doi:10.1111/petr.12880 · Cited by 3 · see citing works
Shields, C. A., Poudel, B., McPherson, K. C., Brown, A. K., Ekperikpe, U. S., Browning, E., Sutton, L., Cornelius, D. C., & Williams, J. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.566403 · Cited by 3 · see citing works
Bakhshayeshkaram, M., Roozbeh, J., Heydari, S. T., Honarvar, B., Dabbaghmanesh, M. H., Ghoreyshi, M., & Lankarani, K. B. (2019) · Galen Medical Journal · doi:10.31661/gmj.v8i.935 · Cited by 3 · see citing works
Berberine in diabetic nephropathy: mechanistic overview
Yanru, Y., Cui, J., & Yan, Y. (2025) · Diabetology International · doi:10.1007/s13340-025-00859-1 · Cited by 2 · see citing works
Chen, I.-J., Hsu, L.-T., Lin, T., & Chen, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.928910 · Cited by 2 · see citing works
Al-Shamma, Z. A., Hasan, K., & Zahraw, S. (2014) · Journals & Books Hosting (International Knowledge Sharing Platform) · Cited by 2 · see citing works
Kachhawa, P., & Sinha, V. (2019) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v10i5.24688 · Cited by 2 · see citing works
Food Metabolism and Chronic Diseases
Tiwari, R., Yadav, A., Hamsa, S., & Dhewa, T. (2023) · Wiley eBooks · doi:10.1002/9781394229116.ch16 · Cited by 2 · see citing works
Lipoprotein (a) and Cardiovascular Risk
Peromingo, J. A. D. (2012) · InTech eBooks · doi:10.5772/31174 · Cited by 1 · see citing works
Dislipidemia associada à doença renal crônica – Revisão de literatura
Marques, F. S., da Silva, A. L. M., & Couto, R. D. (2015) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v13i2.12444 · Cited by 1 · see citing works
Tony, E. E., Saleem, T., Zakhary, M. M., Ahmed, N. S., & Kamel, S. (2016) · Journal of The Egyptian Society of Nephrology and Transplantation · doi:10.4103/1110-9165.200354 · Cited by 1 · see citing works
STUDY OF LIPID PROFILE IN CHRONIC RENAL FAILURE
Lakshmi, M., Subhashini, Y. R., & R, S. K. S. (2016) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2016/341 · Cited by 1 · see citing works
Lee, J., McMillan, R., Skiadopoulos, L., Bansal, V., Biller, J., Hoppensteadt, D., & Fareed, J. (2018) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029618811090 · Cited by 1 · see citing works
Sarolia, S. P., & Franch, H. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4454-1_27 · Cited by 1 · see citing works
The CKD Patient with Dyslipidemia
Batini, V., & Bianchi, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0515-7_6 · Cited by 1 · see citing works
Lipoproteins and Diabetic Nephropathy
Mäkinen, V., Tolonen, N., & Groop, P. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_14 · Cited by 1 · see citing works
Samimagham, H. R., Barghak, M., & Jahromi, M. K. (2021) · Iranian Journal of Kidney Diseases · doi:10.5254/ijkd.5387 · Cited by 1 · see citing works
Lipid metabolism and causal pathways for cardiovascular disease in chronic kidney disease
van Heyningen, C. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832ff5c7 · Cited by 1 · see citing works
Shamma, Z. A. A. A., & Alani, I. Y. (2018) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.099189
Noshad, H., Nejhad, D. M., Hoseini, P., Montazer, M., Ghamari, B., & Shayan, F. K. (2018) · Journal of Analytical Research in Clinical Medicine · doi:10.15171/jarcm.2018.027
Lipid profile in Chronic Kidney Disease before and after hemodialysis
Kumari, D. R. (2019) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v7i4.21
Kaechawa, P., & Sinha, V. (2019) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2019/641
Lipoprotein metabolism with a focus on COVID 19 kidney patients
Martinez, T. L. D. R., Saldanha, A. L. R., Scartezini, M., Margeotto, A. P. P., Pereira, A., & Gasparoto, A. L. V. (2020) · International Journal of Family & Community Medicine · doi:10.15406/ijfcm.2020.04.00199
Zhan, X., Zeng, C., Zhan, Q., Dong, X., & Chen, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1334091/v1
Lipoproteins and Diabetic Kidney Disease
Sigfrids, F. J., Elonen, N., & Groop, P. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_15
Maurya, H., & Kumar, T. (2018) · Archives of Nephrology · doi:10.22259/2639-3573.0101006
Effect of HDF on obestatin level as a marker of malnutrition in hemodialysis patients
Abdelmohsen, W., Youssef, A. M., & Hassan, M. S. (2025) · Journal of The Egyptian Society of Nephrology and Transplantation · doi:10.4103/jesnt.jesnt_10_24
Zhao, W., Li, J., Zhang, X., Zhou, X., Xu, J., Liu, X., & Liu, Z. (2020) · Figshare · doi:10.6084/m9.figshare.12380981
- Authors
- Kaysen, G. A.
- Affiliations
- United States Department of Veterans Affairs (US)
- Corresponding author
- Kaysen, George A.
- Venue
- Journal of Renal Nutrition
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 19
- Issue
- 1
- Pages
- 73-77
- ISSN
- 1051-2276 (ISSN-L)
- OpenAlex
- W1981618554
- Cited by
- 102
- References
- 42
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 6 · 2021: 4 · 2020: 11 · 2019: 7 · 2018: 6 · 2017: 7 · 2016: 11 · 2015: 4 · 2014: 6 · 2013: 9 · 2012: 8
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Renal Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Keywords
- chronic kidney disease, lipid metabolism, lipoprotein metabolism, cardiovascular risk, HDL cholesterol, lipoprotein(a), apolipoprotein B, lipoprotein clearance, lipoprotein lipase, HDL3, oxidized LDL, triglycerides, dialysis patients, cardiovascular mortality
- MeSH terms
- Cardiovascular Diseases, Humans, Hyperlipidemias, Kidney Failure, Chronic, Lipids, Lipoproteins, Lipoproteins, HDL, Lipoproteins, LDL, Risk Factors, Triglycerides, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
